Eyenovia to Participate in Two Upcoming Investor Conferences

NEW YORK, July 07, 2021 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN), a clinical stage ophthalmic company developing a pipeline of advanced therapeutics based on its proprietary microdose array print (MAP™) platform technology, today announced that management will present a corporate overview and host one-one-one meetings at the Ladenburg Thalmann 2021 Healthcare Conference, being held virtually July 13-14, 2021, and host one-on-meetings at the William Blair Biotech Focus Conference 2021, being held virtually July 14-15, 2021.

Details of the Ladenburg presentation are below:

About Eyenovia, Inc.

Eyenovia, Inc. (NASDAQ: EYEN) is a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose array print (MAP) therapeutics. Eyenovia is currently focused on the late-stage development of microdosed medications for presbyopia, myopia progression and mydriasis. For more information, visit www.eyenovia.com.

The Eyenovia Corporate Information slide deck may be found at ir.eyenovia.com/events-and-presentations.

Eyenovia Contact:Eyenovia, Inc.John GandolfoChief Financial Officer[email protected]

Eyenovia Investor Contact:Eric RibnerLifeSci Advisors, LLC[email protected](646) 751-4363

Eyenovia Media Contact:Sam ChoinskiPazanga Health Communications[email protected](603) 489-5964

You May Also Be Interested In

• Steelworkers back Canada holding the line on trade, call for a stronger response to protect Canadian jobs and industry
• Tallgrass Announces Open Season for the Pony Express Pipeline
• Apple TV's 'Acapulco,' Andy Garcia Lead Winners and Honorees at '41st Annual Imagen Awards' Celebrating Latino Entertainment